Literature DB >> 19923463

New design of MHC class II tetramers to accommodate fundamental principles of antigen presentation.

Elise Landais1, Pablo A Romagnoli, Adam L Corper, John Shires, John D Altman, Ian A Wilson, K Christopher Garcia, Luc Teyton.   

Abstract

Direct identification and isolation of Ag-specific T cells became possible with the development of MHC tetramers, based on fluorescent avidins displaying biotinylated peptide-MHC complexes. This approach, extensively used for MHC class I-restricted T cells, has met very limited success with class II peptide-MHC complex tetramers (pMHCT-2) for the detection of CD4(+)-specific T cells. In addition, a very large number of these reagents, although capable of specifically activating T cells after being coated on solid support, is still unable to stain. To try to understand this puzzle and design usable tetramers, we examined each parameter critical for the production of pMHCT-2 using the I-A(d)-OVA system as a model. Through this process, the geometry of peptide-MHC display by avidin tetramers was examined, as well as the stability of rMHC molecules. However, we discovered that the most important factor limiting the reactivity of pMHCT-2 was the display of peptides. Indeed, long peptides, as presented by MHC class II molecules, can be bound to I-A/HLA-DQ molecules in more than one register, as suggested by structural studies. This mode of anchorless peptide binding allows the selection of a broader repertoire on single peptides and should favor anti-infectious immune responses. Thus, beyond the technical improvements that we propose, the redesign of pMHCT-2 will give us the tools to evaluate the real size of the CD4 T cell repertoire and help us in the production and testing of new vaccines.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19923463      PMCID: PMC2795019          DOI: 10.4049/jimmunol.0902493

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  39 in total

Review 1.  Generation of MHC-peptide tetramers: a new opportunity for dissecting T-cell immune responses.

Authors:  P Bousso
Journal:  Microbes Infect       Date:  2000-04       Impact factor: 2.700

2.  Cutting edge: detection of antigen-specific CD4+ T cells by HLA-DR1 oligomers is dependent on the T cell activation state.

Authors:  T O Cameron; J R Cochran; B Yassine-Diab; R P Sékaly; L J Stern
Journal:  J Immunol       Date:  2001-01-15       Impact factor: 5.422

Review 3.  Present difficulties and future promise of MHC multimers in autoimmune exploration.

Authors:  W Ferlin; N Glaichenhaus; E Mougneau
Journal:  Curr Opin Immunol       Date:  2000-12       Impact factor: 7.486

4.  Detection of low-avidity CD4+ T cells using recombinant artificial APC: following the antiovalbumin immune response.

Authors:  Valérie I Mallet-Designe; Thomas Stratmann; Dirk Homann; Francis Carbone; Michael B A Oldstone; Luc Teyton
Journal:  J Immunol       Date:  2003-01-01       Impact factor: 5.422

5.  T cells distinguish MHC-peptide complexes formed in separate vesicles and edited by H2-DM.

Authors:  Zheng Pu; Scott B Lovitch; Elizabeth K Bikoff; Emil R Unanue
Journal:  Immunity       Date:  2004-04       Impact factor: 31.745

6.  Use of MHC class II tetramers to investigate CD4+ T cell responses: problems and solutions.

Authors:  Virginia Cecconi; Monica Moro; Sara Del Mare; Paolo Dellabona; Giulia Casorati
Journal:  Cytometry A       Date:  2008-11       Impact factor: 4.355

7.  Defective TCR expression in transgenic mice constructed using cDNA-based alpha- and beta-chain genes under the control of heterologous regulatory elements.

Authors:  M J Barnden; J Allison; W R Heath; F R Carbone
Journal:  Immunol Cell Biol       Date:  1998-02       Impact factor: 5.126

8.  Engineering protein for X-ray crystallography: the murine Major Histocompatibility Complex class II molecule I-Ad.

Authors:  C A Scott; K C Garcia; E A Stura; P A Peterson; I A Wilson; L Teyton
Journal:  Protein Sci       Date:  1998-02       Impact factor: 6.725

Review 9.  Tricks with tetramers: how to get the most from multimeric peptide-MHC.

Authors:  Linda Wooldridge; Anna Lissina; David K Cole; Hugo A van den Berg; David A Price; Andrew K Sewell
Journal:  Immunology       Date:  2009-02       Impact factor: 7.397

10.  Visualizing antigen specific CD4+ T cells using MHC class II tetramers.

Authors:  Eddie A James; Rebecca LaFond; Ivana Durinovic-Bello; William Kwok
Journal:  J Vis Exp       Date:  2009-03-06       Impact factor: 1.355

View more
  36 in total

1.  Diabetogenic T cells recognize insulin bound to IAg7 in an unexpected, weakly binding register.

Authors:  Brian D Stadinski; Li Zhang; Frances Crawford; Philippa Marrack; George S Eisenbarth; John W Kappler
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-01       Impact factor: 11.205

2.  Distinct evolutionary strategies of human leucocyte antigen loci in pathogen-rich environments.

Authors:  Alicia Sanchez-Mazas; Jean-François Lemaître; Mathias Currat
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2012-03-19       Impact factor: 6.237

3.  Differential scanning fluorimetry based assessments of the thermal and kinetic stability of peptide-MHC complexes.

Authors:  Lance M Hellman; Liusong Yin; Yuan Wang; Sydney J Blevins; Timothy P Riley; Orrin S Belden; Timothy T Spear; Michael I Nishimura; Lawrence J Stern; Brian M Baker
Journal:  J Immunol Methods       Date:  2016-02-18       Impact factor: 2.303

Review 4.  MHC class II tetramers.

Authors:  Gerald T Nepom
Journal:  J Immunol       Date:  2012-03-15       Impact factor: 5.422

5.  In situ detection of autoreactive CD4 T cells in brain and heart using major histocompatibility complex class II dextramers.

Authors:  Chandirasegaran Massilamany; Arunakumar Gangaplara; Ting Jia; Christian Elowsky; Qingsheng Li; You Zhou; Jay Reddy
Journal:  J Vis Exp       Date:  2014-08-01       Impact factor: 1.355

6.  Position β57 of I-Ag7 controls early anti-insulin responses in NOD mice, linking an MHC susceptibility allele to type 1 diabetes onset.

Authors:  Louis Gioia; Marie Holt; Anne Costanzo; Siddhartha Sharma; Brian Abe; Lisa Kain; Maki Nakayama; Xiaoxiao Wan; Andrew Su; Clayton Mathews; Yi-Guang Chen; Emil Unanue; Luc Teyton
Journal:  Sci Immunol       Date:  2019-08-30

Review 7.  Interrogating the repertoire: broadening the scope of peptide-MHC multimer analysis.

Authors:  Mark M Davis; John D Altman; Evan W Newell
Journal:  Nat Rev Immunol       Date:  2011-07-15       Impact factor: 53.106

8.  Negative selection and peptide chemistry determine the size of naive foreign peptide-MHC class II-specific CD4+ T cell populations.

Authors:  H Hamlet Chu; James J Moon; Andrew C Kruse; Marion Pepper; Marc K Jenkins
Journal:  J Immunol       Date:  2010-09-22       Impact factor: 5.422

9.  Highly activated cytotoxic CD8 T cells express protective IL-10 at the peak of coronavirus-induced encephalitis.

Authors:  Kathryn Trandem; Jingxian Zhao; Erica Fleming; Stanley Perlman
Journal:  J Immunol       Date:  2011-02-11       Impact factor: 5.422

10.  T cells control the generation of nanomolar-affinity anti-glycan antibodies.

Authors:  Zinaida Polonskaya; Shenglou Deng; Anita Sarkar; Lisa Kain; Marta Comellas-Aragones; Craig S McKay; Katarzyna Kaczanowska; Marie Holt; Ryan McBride; Valle Palomo; Kevin M Self; Seth Taylor; Adriana Irimia; Sanjay R Mehta; Jennifer M Dan; Matthew Brigger; Shane Crotty; Stephen P Schoenberger; James C Paulson; Ian A Wilson; Paul B Savage; M G Finn; Luc Teyton
Journal:  J Clin Invest       Date:  2017-03-13       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.